🔎 Trials Near Me

Home › Multiple Sclerosis › Illinois

Pag-aaral pangklinika para sa Multiple Sclerosis sa Illinois

19 pag-aaral para sa Multiple Sclerosis ang naghahanap ng mga kalahok sa mga site sa Illinois.

Mga Lungsod sa Illinois

Opisyal na teksto ng pag-aaral (English)

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

  • TG Therapeutics Investigational Trial Site, Chicago
  • TG Therapeutics Investigational Trial Site, Chicago
  • TG Therapeutics Investigational Trial Site, Evanston
  • at 1 pa
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT06433752

Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis

  • Consultants in Neurology- Site Number : 8400020, Northbrook
Nagre-recruitPhase 3
Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07325292

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

  • Rush University Medical Center, Chicago
  • University of Chicago Medical Center, Chicago
Nagre-recruitPhase 2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07002034

Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis

  • University of Chicago Medical Center, Chicago
Nagre-recruitPhase 3
Edad 10 hanggang 17 · Lahat ng kasarian · Na-update Set 10, 2026 · NCT06408259

Evaluation of the Safety and Efficacy of a Full-Body Electrostimulation Garment for Individuals With Neurological and Neuromuscular Conditions That Cause Spasticity, Hyperreflexia, and Pain

  • Shirley Ryan AbilityLab, Chicago
Nagre-recruit
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT07132775

A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

  • Northwestern Memorial Hospital, Chicago
Nagre-recruitPhase 3
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Hul 29, 2026 · NCT07225504

Ocrevus Zunovo for MS: Mixed Methods

  • Northwestern Memorial Hospital, Chicago
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 20, 2026 · NCT07710105

Exercise Rehabilitation Program in MS Who Use Wheelchairs as a Primary Mobility Device

  • University of Illinois at Chicago, Chicago
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 13, 2026 · NCT06410261

Functional Balance Intervention in Multiple Sclerosis

  • University of Illinois at Chicago, Chicago
Nagre-recruit
Edad 18 hanggang 90 · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT06341023

Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis

  • University of Illinois at Chicago, Chicago
Nagre-recruit
Edad 18 hanggang 64 · Lahat ng kasarian · Na-update Hun 4, 2026 · NCT05051618

Nomad P-KAFO Study

  • Shirley Ryan AbilityLab, Chicago
Nagre-recruit
Edad 18 hanggang 89 · Lahat ng kasarian · Na-update May 11, 2026 · NCT05644522

Fall Prevention Among People With Spinal Cord Injury and Multiple Sclerosis Who Use Wheelchairs and Scooters

  • Disability Participation and Quality of Life (DPQOL) Laboratory, Urbana
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update May 11, 2026 · NCT07167680

Intermittent Hypoxia in Persons With Multiple Sclerosis

  • Shirley Ryan AbilityLab, Chicago
Nagre-recruit
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Mar 20, 2026 · NCT06276634

People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonists

  • Northwestern Memorial Hospital, Chicago
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Mar 17, 2026 · NCT07207148

Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis

  • Northwestern Memorial Hospital, Chicago
Nagre-recruitPhase 4
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Mar 17, 2026 · NCT07225361

Effects of Acute Intermittent Hypoxia on Neuroplasticity in MS

  • Shirley Ryan AbilityLab, Chicago
Nagre-recruit
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Peb 23, 2026 · NCT06390930

Home Based Functional Balance Intervention for Multiple Sclerosis

  • University of Illinois at Chicago, Chicago
Nagre-recruit
Edad 40 hanggang 90 · Lahat ng kasarian · Na-update Ene 21, 2026 · NCT07355387

An Individualized-health eLibrary App for People With Multiple Sclerosis

  • University of Illinois Urbana-Champaign, Champaign
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 24, 2025 · NCT05124600

Remote Evaluation of MIND Diet

  • University of Illinois Urbana-Champaign, Urbana
Nagre-recruit
Edad 18 hanggang 64 · Lahat ng kasarian · Na-update Hun 27, 2024 · NCT06450977

Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.